Sort
85,873 grants matching “alzheimers”
Center for Targeted Therapeutics
$2,235,000Igor B Roninson · University Of South Carolina At Columbia · P20 · FY2021 · GM
Center for Targeted Therapeutics
$2,235,000Hippokratis Kiaris · University Of South Carolina At Columbia · P20 · FY2023 · GM
Vulnerability of the ascending arousal network to alpha-synuclein pathology
$2,234,905Georgina Aldridge · University Of Iowa · RF1 · FY2024 · NS
Frontotemporal Dementias: Genotypes and Phenotypes
$2,234,654Virginia M Lee · University Of Pennsylvania · P01 · FY2019 · AG
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$2,234,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2022 · AG
Investigations of targets, mechanisms, and optimal delivery of therapeutic ketosis for functional longevity and treatment of Alzheimer's disease
$2,234,244Gino A Cortopassi · University Of California At Davis · P01 · FY2023 · AG
Promoting Engagement and Clinical Trial Readiness for Alzheimer's Disease and Related Dementias Among Underserved Sexual and Gender Minorities
$2,234,191Jason Dane Flatt · University Of Nevada Las Vegas · RF1 · FY2025 · NS
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
$2,234,180Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2018 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
$2,233,154Anita L Destefano · Boston University Medical Campus · U01 · FY2018 · AG
Identification of plasma lipoprotein proteins and lipids as biomarkers of innate-immunity and vascular contributions to Alzheimer's disease and Alzheimer's disease-related dementias in older adults
$2,232,476Danni Li · University Of Minnesota · RF1 · FY2023 · AG
In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI
$2,231,917Dmitriy A Yablonskiy · Washington University · RF1 · FY2022 · AG
The Function and Mechanisms of Autophagy in Spinal Cord Injury
$2,231,793Junfang Wu · University Of Maryland Baltimore · RF1 · FY2022 · NS
Mechanisms of Angiotensin I Converting Enzyme in Alzheimer's disease
$2,231,406Robert J Vassar · Northwestern University At Chicago · RF1 · FY2023 · AG
MRI: Acquisition of a Siemens MAGNETOM Prisma 3-Tesla MRI
$2,231,298Geoffrey Boynton · University Of Washington · · FY2018 · SBE
COBRE GRANT
$2,230,641Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2017 · GM
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
$2,229,803Tamara Dubowitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
White Matter Restoration in Vascular Cognitive Impairment and dementia
$2,229,700Guodong Cao · University Of Pittsburgh At Pittsburgh · RF1 · FY2020 · NS
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,229,662Thomas M Burbacher · University Of Washington · P42 · FY2021 · ES
Alzheimer's Disease Research Center
$2,229,013Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · AG
UC Irvine AD Translational Center for Disease Model Resources
$2,228,345Frank M Laferla · University Of California-Irvine · U54 · FY2018 · AG
Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry
$2,228,010Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2025 · AG
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
$2,226,344Robert A Stern · Boston University Medical Campus · U01 · FY2019 · NS
VGo-Assist, A Mobile Telepresence Robot to Engage Persons with Alzheimer's Disease and Related Dementias
$2,225,928Steve Normandin · Vecna Technologies, Inc. · R44 · FY2021 · AG
Investigating Informal Caregivers' Involvement in End-of-Life Care among Assisted Living Residents with Advanced Dementia and its Influence on Resident and Caregiver Outcomes
$2,224,871Molly M Perkins · Emory University · RF1 · FY2021 · AG
The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID
$2,224,569D. Richard Milner · San Diego Biomedical Research Institute · RF1 · FY2021 · NS